Le Lézard
Classified in: Health
Subjects: SVY, POL

No World Borders Publishes Affordable Care Act Risk Corridor Analysis


NEWPORT BEACH, Calif., March 3, 2021 /PRNewswire/ -- No World Borders, Inc. announced that its CEO, Michael F. Arrigo published an analysis of risk corridors under the Affordable Care Act.

Michael F. Arrigo, C.E.O. of No World Borders, said, "With the House approval of the American Rescue Plan Act, it has approved broader subsidies. These subsidies are intended to insure more of the currently uninsured and encourage more states to expand Medicaid.  The increase in the number of insureds increases the risk pool.  The ARPA should encourage us to look back at the lessons learned when the Affordable Care Act started. When Health Insurance Exchanges were launched, insurers did not have the actuarial experience to estimate newly set premiums, risk rates and utilization.  Risk corridors were intended to limit both the amount of money that a health insurance plan can make -- and how much it can lose -- during the first three years.  In part, the intent was to encourage insurers to enter the HIE markets by mitigating their risk, "...to protect against the effects of adverse selection..."  Once risk corridors were developed Congress refused to fund the program.  This ultimately led to the lawsuit before the Supreme Court: Maine Community Health Options v. the United States."

The new retrospective analysis evaluates whether risk corridors benefit the insureds that the Affordable Care Act is designed to cover.  Topics include:

  1. Risk Corridor Litigation Timeline
  2. History of Risk Corridors in the Affordable Care Act
  3. How Risk Corridor Calculations Work
  4. Risk Corridor Controversy
  5. Expected Benefits to the Consumer via Market Competition
  6. Using Medicare Part D as a Basis
  7. Actuarial Analysis of Costs and Benefits to Consumers and the Government in Plans with Risk Corridors
  8. Affordable Care Act Medical Loss Ratio (MLR) Standard
  9. Expenditures to Control or Contain Costs Such as Fraud are Excluded from MLR

About Michael F Arrigo

Michael F. Arrigo is the CEO of No World Borders, a healthcare data regulations and economics firm.  He serves as an expert witness regarding the Affordable Care Act.  In his work he also advises clients regarding risk adjustment in Medicare Advantage plans, Medicare Part D, and Accountable Care Organizations under the Affordable Care Act. 

About No World Borders

No World Borders was founded in 2000.  The company has a group of experts and technology focused on solving complex healthcare data, regulations, and economics and has offices throughout the U.S. The company news coverage and examples of client success stories are listed on its website.

 

SOURCE No World Borders


These press releases may also interest you

at 06:30
The "Sample Preparation Market by Product (Workstation, Instrument {Pipette, Washer, Centrifuge, Grinder}, Consumable {Kits, Filters, Plates}) Technique (Solid Phase Extraction, Purification) Application (Drug Discovery, Diagnostic) - Global Forecast...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....



News published on and distributed by: